Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy

Acute myeloid leukemia (AML) is a deadly hematological malignancy with frequent disease relapse. The biggest challenge for AML therapy is the lack of methods to target and kill the heterogeneous leukemia cells, which lead to disease relapse. Here, we describe a near-infrared (NIR) fluorescent dye, I...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chi, Liu, Tao, Luo, Peng, Gao, Li, Liao, Xingyun, Ma, Le, Jiang, Zhongyong, Liu, Dengqun, Yang, Zeyu, Jiang, Qingzhi, Wang, Yu, Tan, Xu, Luo, Shenglin, Wang, Yang, Shi, Chunmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775779/
https://www.ncbi.nlm.nih.gov/pubmed/33523835
http://dx.doi.org/10.1126/sciadv.abb6104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775779/
https://www.ncbi.nlm.nih.gov/pubmed/33523835
http://dx.doi.org/10.1126/sciadv.abb6104

Ejemplares similares